| Literature DB >> 31915896 |
Joana B Pereira1,2, Theresa M Harrison3, Renaud La Joie4, Suzanne L Baker5, William J Jagust3,5.
Abstract
PURPOSE: The abnormal deposition of tau begins before the onset of clinical symptoms and seems to target specific brain networks. The aim of this study is to identify the spatial patterns of tau deposition in cognitively normal older adults and assess whether they are related to amyloid-β (Aβ), APOE, sex, and longitudinal cognitive decline.Entities:
Keywords: APOE; Amyloid; Cognitive decline; Flortaucipir PET; Older adults; Sex
Mesh:
Substances:
Year: 2020 PMID: 31915896 PMCID: PMC7338820 DOI: 10.1007/s00259-019-04669-x
Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN: 1619-7070 Impact factor: 9.236
Characteristics of the sample
| All subjects ( | Aβ− ( | Aβ+ ( | ApoE ε2/ε3 ( | ApoE ε3/ε3 ( | ApoE ε3/ε4 ( | Men ( | Women ( | |
|---|---|---|---|---|---|---|---|---|
| Age (years) | 76.4 (6.3) | 76.3 (7.4) | 76.6 (4.3) | 75.2 (7.6) | 76.4 (6.8) | 76.6 (4.6) | 77.1 (6.7) | 75.9 (6.0) |
| Sex (m/f) | 45/69 | 27/40 | 18/29 | 7/4 | 25/46 | 12/16 | - | - |
| Education (years)a,b | 16.8 (1.8) | 17.2 (1.8) | 16.4 (1.8) | 16.3 (0.6) | 17.2 (1.7) | 16.4 (2.3) | 17.1 (1.6) | 16.7 (2.0) |
| PiB DVRa,b,c,d | 1.2 (0.2) | 1.02 (0.0) | 1.34 (0.3) | 1.02 (0.04) | 1.09 (0.16) | 1.30 (0.3) | 1.12 (0.2) | 1.17 (0.2) |
| APOE (e2/e3/e4)a | 11/71/28 | 10/52/5 | 1/19/23 | - | - | - | 7/25/12 | 4/46/16 |
| MMSE | 28.8 (1.2) | 28.9 (1.0) | 28.5 (1.4) | 29.2 (0.8) | 28.8 (1.2) | 28.5 (1.3) | 28.8 (1.2) | 28.7 (1.2) |
| Memory | 0.02 (0.9) | 0.14 (0.9) | − 0.15 (0.9) | 0.54 (0.9) | − 0.04 (0.9) | 0.10 (0.8) | − 0.08 (0.8) | 0.09 (1.0) |
| Executive functione | 0.06 (0.7) | 0.11 (0.7) | − 0.01 (0.7) | 0.17 (0.9) | 0.01 (0.7) | 0.22 (0.7) | − 0.12 (0.6) | 0.18 (0.8) |
Values in the table correspond to means followed by (standard deviation), except for sex and APOE, which correspond to number of subjects in each category
aSignificant differences between Aβ− and Aβ+ groups (p < 0.05)
bSignificant differences between ApoE ε2/ε3 and ApoE ε3/ε3 groups (p < 0.05)
cSignificant differences between ApoE ε2/ε3 and ApoE ε3/ε4 groups (p < 0.05)
dSignificant differences between ApoE ε3/ε3 and ApoE ε3/ε4 groups (p < 0.05)
eSignificant differences between men and women (p < 0.05)
Fig. 1Spatial patterns of tau deposition in aging. We identified 10 independent components for tau in the analyses of FTP data. These components were thresholded with a Z score > 2.0
Fig. 2Tau burden within spatial patterns differs by Aβ, APOE, and sex in older adults. We found significantly higher tau burden in some of the spatial patterns in Aβ-positive compared with Aβ-negative peers, APOE ε3ε3 compared with ε2ε3 carriers, and in women compared with men. Asterisk indicates significant differences between groups, after regressing out the effects of age, sex, education for Aβ groups; age, sex, education, and PiB DVR for APOE groups; and age, education, and PiB DVR for sex groups. All results were corrected for multiple comparisons using FDR (q < 0.05)
Fig. 3Progression of tau pathology across different spatial patterns. We used the means and standard deviations of Aβ− individuals with entorhinal tau < 1.2 to identify individuals with high tau in the different spatial patterns. The patterns that were determined to show increased binding in a greater number of participants were considered to be regions of early tau deposition. Using this approach, we found a spreading order of tau across the spatial patterns from limbic and ventral areas, to lateral and medial posterior regions, and frontal and sensorimotor cortices. Patterns colored in light red correspond to a newly added stage, whereas patterns colored in dark red correspond to previous stage